Cargando…
Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients
BACKGROUND: Human cytomegalovirus (HCMV) is an oncomodulatory human herpesvirus that has been detected in glioblastoma (GBM) and is associated with worse prognosis in patients with the disease. The effects of HCMV systemic infection on survival in GBM patients, however, are largely unknown. We aimed...
Autores principales: | Foster, Haidn, Piper, Keenan, DePledge, Lisa, Li, Hsin-Fang, Scanlan, James, Jae-Guen, Yoon, Boeckh, Michael, Cobbs, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212888/ https://www.ncbi.nlm.nih.gov/pubmed/32642656 http://dx.doi.org/10.1093/noajnl/vdz020 |
Ejemplares similares
-
Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges
por: Piper, Keenan, et al.
Publicado: (2021) -
Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review
por: Piper, Keenan, et al.
Publicado: (2019) -
Detection of Human Papillomavirus Integration in Brain Metastases from Oropharyngeal Tumors by Targeted Sequencing
por: McEllin, Brian, et al.
Publicado: (2021) -
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
por: McAdoo, Stephen P., et al.
Publicado: (2017) -
Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
por: Unterberg, M., et al.
Publicado: (2023)